Related Experiment Video
Updated: Nov 24, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Determinants of Use of Biotherapeutics in sub-Saharan Africa
Rajiv Shah1, Dzifa Dey2, Thomas Pietzonka3
1Global Health and Corporate Responsibility, Novartis, Basel, Switzerland.
Abstract:
Biologic drugs are reshaping clinical practice in various disciplines, even while access to them is imbalanced across global settings. In sub-Saharan Africa, biotherapeutics have potential roles to play in the treatment of a range of conditions that include infectious and noncommunicable diseases (NCDs). However, the literature is scarce on guidance for addressing local access challenges, including technical, regulatory, affordability, and other healthcare delivery aspects. This article aims to assess fundamental determinants of use of biologic medicines in sub-Saharan Africa. The purpose is to inform strategic actions of scientists, physicians, policymakers, and other stakeholders that are working to improve access to innovative therapies in low resource parts of the world.
Related Concept Videos
Bioavailability: Influencing Factors
Drug Products: Biologics, Biosimilars and Interchangeables
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Therapeutic Drug Monitoring: Affecting Factors
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability: Overview

